|
| |
| Analytical Technologies to Further R&D, Life Science and Chemical Production |
| |
AnaLabAsia2009, is well placed to serve the growing needs of Asia’s growing industries especially in Analytical & Life Science Instruments, Petrochemical, Biodiesel, Pharmaceutical and Biotechnology. |
| |
|
| |
Analytical and Life Science Instruments Industry |
| |
 |
| |
The global market for analytical instrumentation increased from $26 billion in 2002 to more than $36 billion in 2007. The last few years have been particularly eventful with industry participants reporting record sales driven by robust growth in China and other Asia Pacific areas. |
| |
Basic research and scientific spending remains unabated even in the current recessive global environment. The analytical and life science instruments industry are expected to post solid growth over the next five years. Overall, the analytical instrument market is projected to generate about $49 billion in annual revenues in 2012 fueled by increased initial systems demand. Initial systems accounted for over half of the total market in 2007, while aftermarket and service accounted for 35% and 12%, respectively. |
| |
Separation technologies, which include liquid chromatography, gas chromatography, and other techniques, represent the second largest segment of the analytical instrument market accounting for roughly 17% of the total demand in 2007. This segment is expected to post strong growth over the next five years fueled by the rapid expansion of Asian economies and in particular, China. |
| |
As the dynamics of the industry continue to change, savvy vendors are taking advantage of the new opportunities. Technological improvement, new applications, and explosive growth in emerging geographies are all providing a positive stimulus to the overall analytical instrument market. In particular, life science research and drug development continue to represent an increasingly prominent source of demand.
SDi Global Assessment Report
10th Edition |
| |
Petrochemical Industry |
Shell has plans under consideration for significant new manufacturing investments, including a world-scale styrene monomer/propylene oxide (SMPO) project, to strengthen Shell’s regional product and service portfolio. Shell also predicts that by 2015 ethylene output from producers in the Middle East, China, and other Asia Pacific countries is likely to exceed the combined production of Europe and North America. Longer term, it anticipates increased ethylene production based on a new and growing slate of feedstock ranging from biological sources such as ethanol and agricultural biomass to coal.
Oil and Gas News
August 2008 |
| |
| Biodiesel Industry |
There are several strong drivers of growth in the industry. The sector in Asia Pacific is moving from export markets to stimulating domestic consumption. Countries are introducing blending mandates, either for biofuels as a class, or specifically for diesel, and exploring alternative lower-cost feedstock supplies, such as waste cooking oil and Jatropha.
Frost & Sullivan
November 2007 |
| |
| Pharmaceutical Industry |
The expiry of patents and limited pipeline of blockbuster drugs open up opportunities for developing nations to strengthen their local pharmaceutical industries by entering the arena of generics and traditional medicine. There is also a growing trend among companies to outsource clinical work to contract research organisations, contract manufacture their products, and enter partnerships with other companies in areas like R&D and manufacturing. Companies such as Pfizer and AstraZeneca expect to outsource more than 30% of their manufacturing to Asia.
Frost & Sullivan
April 2008 |
| |
Biotechnology Industry |
Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific biotechnology market in 2007 was more than US$41bn. The region is expected to become a major destination for clinical trials, stem cell research and biogeneric manufacturing. Using pioneering technologies and efficient production methods, Asian countries are also creating competitive niches in the vaccine space.
RNCOS
August 2008 |
